back-arrow-image Search Health Packages, Tests & More

Breast Marker Profile Test

50+ booked in last 3 days

Overview

Breast cancer is one of the most common cancers among women worldwide. Cancer markers or tumour markers are proteins produced by the normal cells as well as cancer cells, but are produced in higher levels by the cancer cells. Breast Marker Profile consists of tests to measure the levels of tumour markers in the blood, urine, and other body fluids. This profile test is used with other tests to confirm a breast cancer diagnosis and decide on the best treatment.

WRITTEN BY: Dr.Shibani R Medical Writer, Medical Affairs 

 

 

 

Read More

Breast Marker Profile Test Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Breast Marker Profile Test with a clear pricing structure.

The Breast Marker Profile Test Price in Mumbai is ₹ 2,035 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

The Breast Marker Profile measures CA 15.3, CEA levels in the blood.

  • This test is done to monitor patients of breast cancer.
  • Serial monitoring is done to compare concentrations before and after treatment to assess effectiveness of treatment given.
  •  The test can help detect recurrence, metastasis and residual cancer
  • This test is not an effective tool for screening as patients with early stages of breast cancer may be negative for this test
  • Patients with lumps in the breast or any suspected signs of breast cancer.
  • Patients already undergoing treatment for cancer.
  • Patients who have completed the treatment to know the disease status.
  • Familial history of breast, ovarian or uterine cancers.
  • Presence of high risk factors for breast cancer.

This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.

 

CEA test

A gross increase of CEA in a patient with compatible symptoms are suggestive of the presence of cancer. The results of this test when done over an interval help monitor condition of the patient and his response to treatment.

CEA levels fall after successful treatment to normal levels in 1-4 months

Levels may increase in certain non-cancerous conditions like smoking, hepatic disease, trauma, ulcerative colitis, pancreatitis, cirrhosis, COPD, Crohn's disease and hypothyroidism.

Patients should do a follow-up testing preferably through the same laboratory as different assays can give different result values on the same sample

CA 15.3

Increased levels are also noted in few cases of carcinomas of ovary, colon, pancreas, lung and certain non-malignant conditions as well.

Levels of CA 15.3 correlate with disease progression

Increase in values in patients treated for breast cancer are indicative of recurrent disease and indicate additional tests or procedures for work-up

Patients should do a follow-up testing preferably through the same laboratory as different assays can give different result values on the same sample.

Carcinoembryonic antigen (CEA) is a glycoprotein and its concentration in blood increases in certain tumours i.e., colorectal cancer, medullary thyroid carcinoma, breast, gastrointestinal tract, liver, lung, ovarian, pancreatic and prostatic cancers.

It is often used for monitoring colorectal & gastrointestinal cancer patients and their response to treatment.

CA 15-3 is a glycoprotein levels of which may be elevated in patients with breast cancer and few cases of carcinomas of ovary, colon, pancreas, lung and non-malignant conditions. This test is done to monitor patients of breast cancer, to know treatment effectiveness in patients undergoing cancer treatment and to monitor the relapse or metastasis status. 

This test is not an effective tool for screening as patients with early stages of breast cancer may be negative for this test.

full medical check up

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
170+ Advanced Labs
lab image
Trusted by Leading Doctors & Hospitals
lab images
Over 2000+ Scientific Officers
reports image
Proficiency Testing for Accurate Reports

Latest Blogs & News

View More
View all